Literature DB >> 27447199

Kinetic and Structural Studies of Interactions between Glycosaminoglycans and Langerin.

Jing Zhao1, Xinyue Liu, Chelsea Kao, Emily Zhang, Quanhong Li1, Fuming Zhang, Robert J Linhardt2.   

Abstract

Langerin, a C-type lectin, is expressed in Langerhans cells. It was reported that langerin binds sulfated glycans, which is an important initial step for its role in blocking human immunodeficiency virus (HIV) transmission by capturing HIV pathogens and mediating their internalization into Birbeck granules for their elimination. It is fundamentally important to understand these interactions at the molecular level for the design of new highly specific therapeutic agents for HIV. Surface plasmon resonance (SPR), which allows for the real-time, direct, quantitative analysis of the label-free molecular interactions, has been used successfully for biophysical characterization of glycosaminoglycan (GAG)-protein interactions. In this study, we report kinetics, structural analysis, and the effects of physiological conditions (e.g., pH, salt concentration, and Ca(2+) and Zn(2+)concentrations) on the interactions between GAGs and langerin using SPR. SPR results revealed that langerin binds to heparin with high affinity (KD ∼ 2.4 nM) and the oligosaccharide length required for the interactions is larger than a tetrasaccharide. This heparin/heparan sulfate-binding protein also interacts with other GAGs, including dermatan sulfate, chondroitin sulfates C-E and KS. In addition, liquid chromatography-mass spectrometry analysis was used to characterize the structure of sulfated glycans that bound to langerin.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27447199     DOI: 10.1021/acs.biochem.6b00555

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Interactions between Sclerostin and Glycosaminoglycans.

Authors:  Fuming Zhang; Jing Zhao; Xinyue Liu; Robert J Linhardt
Journal:  Glycoconj J       Date:  2019-12-11       Impact factor: 2.916

2.  Glycan Determinants of Heparin-Tau Interaction.

Authors:  Jing Zhao; Isabelle Huvent; Guy Lippens; David Eliezer; Anqiang Zhang; Quanhong Li; Peter Tessier; Robert J Linhardt; Fuming Zhang; Chunyu Wang
Journal:  Biophys J       Date:  2017-03-14       Impact factor: 4.033

3.  Novel method for measurement of heparin anticoagulant activity using SPR.

Authors:  Jing Zhao; Xinyue Liu; Anju Malhotra; Quanhong Li; Fuming Zhang; Robert J Linhardt
Journal:  Anal Biochem       Date:  2017-03-18       Impact factor: 3.365

4.  Photoaffinity Probes for the Identification of Sequence-Specific Glycosaminoglycan-Binding Proteins.

Authors:  Amélie M Joffrin; Linda C Hsieh-Wilson
Journal:  J Am Chem Soc       Date:  2020-08-03       Impact factor: 15.419

5.  Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods.

Authors:  Réka Gindele; Krisztina Pénzes-Daku; Gábor Balogh; Judit Kállai; Réka Bogáti; Bálint Bécsi; Ferenc Erdődi; Éva Katona; Zsuzsanna Bereczky
Journal:  Biomolecules       Date:  2021-04-08

6.  Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants.

Authors:  Adrianne L Gelbach; Fuming Zhang; Seok-Joon Kwon; John T Bates; Andrew P Farmer; Jonathan S Dordick; Chunyu Wang; Robert J Linhardt
Journal:  Front Mol Biosci       Date:  2022-08-15

Review 7.  Molecular Recognition in C-Type Lectins: The Cases of DC-SIGN, Langerin, MGL, and L-Sectin.

Authors:  Pablo Valverde; J Daniel Martínez; F Javier Cañada; Ana Ardá; Jesús Jiménez-Barbero
Journal:  Chembiochem       Date:  2020-07-02       Impact factor: 3.461

8.  The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica.

Authors:  Weihua Jin; Wenjing Zhang; Dipanwita Mitra; Martin G McCandless; Poonam Sharma; Ritesh Tandon; Fuming Zhang; Robert J Linhardt
Journal:  Int J Biol Macromol       Date:  2020-09-24       Impact factor: 6.953

Review 9.  Keratan sulfate-based glycomimetics using Langerin as a target for COPD: lessons from studies on Fut8 and core fucose.

Authors:  Yuki Ohkawa; Yoichiro Harada; Naoyuki Taniguchi
Journal:  Biochem Soc Trans       Date:  2021-02-26       Impact factor: 5.407

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.